Draft Specialty Drug List Available for Comment, Responses Due March 12

The draft specialty drug list is now available for public comment.

HHSC will accept comments on the draft SDL until Wednesday, March 12. Stakeholders should submit comments on the Specialty Drug Submission Spreadsheet (Excel). The Specialty Drug Handbook outlines the process for including drugs on the SDL and expectations for external comment.

• Requests for additions to the SDL must include documentation justifying the drug meets three of the four of the rule criteria.
• Requests for removals from the SDL must include documentation justifying the drug does not meet at least one of the rule criteria.
• The form allows justification of criteria #1, #3, and #4. HHSC will verify criteria #2 through a review of drug utilization data.

Drugs marked as "approved" are scheduled for inclusion on the final SDL scheduled for publication in March.